Sage Therapeutics, Inc. 4
4 · Sage Therapeutics, Inc. · Filed Dec 19, 2016
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2016-12-15−1,900→ 165,138 totalExercise: $8.92Exp: 2024-05-21→ Common Stock (1,900 underlying) - Tax Payment
Common Stock
2016-12-15$48.99/sh−346$16,951→ 1,554 total - Exercise/Conversion
Common Stock
2016-12-15$8.92/sh+1,900$16,948→ 1,900 total
Footnotes (2)
- [F1]The disposition reported on this Form 4 were effected pursuant to a stock swap using existing employee stock purchase (espp) shares.
- [F2]The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option shall vest in full on May 5, 2018, subject to continued service through such date.